Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
暂无分享,去创建一个
X. Jing | T. Kiziltepe | Haihua Xiao | G. Noble | J. F. Stefanick | B. Bilgicer | Ruogu Qi | Jared F. Stefanick | Basar Bilgicer
[1] Zijian Guo,et al. Targeting and delivery of platinum-based anticancer drugs. , 2013, Chemical Society reviews.
[2] H. Maeda. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[3] X. Jing,et al. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[4] X. Jing,et al. A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. , 2012, Biomaterials.
[5] A. Pandey,et al. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity , 2012, Proceedings of the National Academy of Sciences.
[6] X. Jing,et al. Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[7] M. Suckow,et al. Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo , 2012, Blood cancer journal.
[8] Daan Frenkel,et al. Receptor-mediated endocytosis of nanoparticles of various shapes. , 2011, Nano letters.
[9] A. Quiroga. Non-classical structures among current platinum complexes with potential as antitumor drugs. , 2011 .
[10] X. Jing,et al. Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II). , 2011, Biomaterials.
[11] Kirsten Sandvig,et al. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .
[12] Shonagh Walker,et al. The status of platinum anticancer drugs in the clinic and in clinical trials. , 2010, Dalton transactions.
[13] Gianfranco Pasut,et al. PEG conjugates in clinical development or use as anticancer agents: an overview. , 2009, Advanced drug delivery reviews.
[14] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[15] P. Sadler,et al. A potent cytotoxic photoactivated platinum complex , 2007, Proceedings of the National Academy of Sciences.
[16] Celia Quevedo,et al. Biochemical mechanisms of cisplatin cytotoxicity. , 2007, Anti-cancer agents in medicinal chemistry.
[17] P. Sadler,et al. Photoactivatable platinum complexes. , 2007, Anti-cancer agents in medicinal chemistry.
[18] Mika Kettunen,et al. Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. , 2006, Current medicinal chemistry.
[19] M. Hall,et al. The Discovery and Development of Cisplatin , 2006 .
[20] M. Jakupec,et al. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. , 2005, Current medicinal chemistry.
[21] M. Hall,et al. The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. , 2004, Journal of inorganic biochemistry.
[22] T. Boulikas,et al. Cisplatin and platinum drugs at the molecular level. (Review). , 2003, Oncology reports.
[23] J. Collins,et al. Multi-nuclear platinum complexes as anti-cancer drugs , 2003 .
[24] R. Jain,et al. Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.
[25] J. Perez,et al. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. , 2003, Current medicinal chemistry.
[26] M. Hall,et al. Platinum(IV) antitumour compounds: their bioinorganic chemistry , 2002 .
[27] José Perez,et al. Is cisplatin-induced cell death always produced by apoptosis? , 2001, Molecular pharmacology.
[28] S. Lippard,et al. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.
[29] N. Nissen,et al. Membrane transport of anthracyclines. , 1982, Pharmacology & therapeutics.